Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)

Detalles Bibliográficos
Autores principales: Schwarz, Lilian, Vernerey, Dewi, Bachet, Jean-Baptiste, Tuech, Jean-Jacques, Portales, Fabienne, Michel, Pierre, Cunha, Antonio Sa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053072/
https://www.ncbi.nlm.nih.gov/pubmed/32126964
http://dx.doi.org/10.1186/s12885-020-6678-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053072/
https://www.ncbi.nlm.nih.gov/pubmed/32126964
http://dx.doi.org/10.1186/s12885-020-6678-x

Ejemplares similares